Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Cytek Biosciences Q2 Earnings

  Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM.

Here’s what investors need to know about the announcement.

Earnings

Cytek Biosciences beat estimated earnings by 50.0%, reporting an EPS of $0.03 versus an estimate of $0.02.

Revenue was up $9.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 9.72% increase in the share price the next day.

 

To track all earnings releases for Cytek Biosciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For World Acceptance

By Benzinga Insights
Today, 3:00 PM
World Acceptance (NASDAQ:WRLD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that World Acceptance will report an earnings per share (EPS) of $6.14.

WRLD

Read More

Earnings Preview: Tilly’s

By Benzinga Insights
Today, 3:00 PM
Tilly's (NYSE:TLYS) is set to give its latest quarterly earnings report on Thursday, 2022-06-02. Here's what investors need to know before the announcement. Analysts estimate that Tilly's will report an earnings per share (EPS) of $0.02.

TLYS